Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision has been updated from v3.5.2 to v3.5.3, indicating a new version of the page. The underlying study information and content remain the same.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded Revision: v3.5.0; Deleted Revision: v3.4.3.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page. This appears to be a software/version bump with no visible changes to study content or user-facing features.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page now shows a minor site revision label 'Revision: v3.4.2' and removes the prior 'Revision: v3.4.1' label, including a government funding status notice.SummaryDifference0.2%

- Check99 days agoChange DetectedNew documents and external references were added to the study page, including the Study Protocol PDF, Statistical Analysis Plan PDF, IPD sharing information, and publications from PubMed.SummaryDifference98%

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.